Ultralife Q3 Sales Rise 11.3% to $48.3 Million; Operating Income Reaches $3.2 Million

Ultralife reported Q3 2026 revenue of $48.3M, up 11.3% YoY, with operating income of $3.2M, reversing a prior-year loss. Net income was $2.4M, or $0.14 per share. The company cited increased demand in battery and energy products, a record backlog of $136M, and an expected acquisition by EnerSys in Q1 2027.

Original reporting
Published Nov 9, 2026, 8:43 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 9, 2026, 8:48 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Ultralife Q3 Sales Rise 11.3% to $48.3 Million; Operating Income Reaches $3.2 Million — source image
Decision brief

The 30-second read

$ULBIBullishMed
01

Why it matters

The quarter shows a clear operating income swing versus the prior-year quarter, supported by higher government and defense demand and a large conformal wearable battery order. Record backlog strengthens forward visibility, while the EnerSys deal shifts the valuation framework toward deal-close probability and timing.

02

Market read

This is a company-specific fundamentals update with a deal catalyst, likely affecting near-term positioning around margin trajectory and acquisition-close expectations.

03

What to watch

The acquisition by EnerSys is a major overhang. Traders should monitor deal-related risks (regulatory/closing conditions) and whether backlog converts to revenue at attractive margins.

Relevance 8/10Novelty 7/10Timing: deal-close expectations into Q1 2027, following today’s Q3 print

Background

Ultralife is a battery and energy products and communications systems supplier, and it has agreed to be acquired by EnerSys in an all-cash transaction.

Company-level read

Ticker impact

$ULBIBullishMedium confidence
Context

Ultralife reported Q3 2026 revenue of $48.3M (+11.3% YoY) and operating income of $3.2M, plus record backlog of $136.0M.

Expected impact

Likely upward bias as investors price in margin improvement and backlog strength, with additional upside if deal-close expectations firm.

Evidence & confidence

The article provides fresh quarterly financials (revenue, operating income, EBITDA) and a new record backlog figure, both direct fundamentals. It also reiterates the acquisition expected to close in Q1 2027, which can influence valuation and risk premium.

Market effects

Defense and government battery demand appears to be supporting Ultralife’s Battery and Energy segment, potentially reinforcing sentiment toward niche defense battery suppliers.

No explicit regional market catalyst beyond company-specific backlog and acquisition timeline.

Oil and gas softness is cited as a headwind for commercial sales, but the article does not quantify broader global impacts.

Counterpoint

Communications Systems sales declined and commercial oil and gas softness persists, so the profitability rebound may be uneven across segments.

Key entities

  • Ultralife

    Reported Q3 2026 revenue, operating income, adjusted EBITDA, record backlog, and reiterated EnerSys acquisition timing.

  • EnerSys

    Agreed to acquire Ultralife in an all-cash transaction valued at about $320 million, expected to close in Q1 2027.

Related articles

$ULBIHighAI 8/10

Ultralife Corporation Reports Third Quarter Results

ULTRALIFE CORP (ULBI) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Ultralife Corporation Reports Third Quarter Results NEWARK, N.Y. – November 5, 2026 -- Ultralife Corporation (NASDAQ: ULBI) reported operating results for the third quarter ended September 30, 2026 with the following results: ● Sales of $48.3 million compared to $43.

$ENSHighAI 9/10

EnerSys to Buy Ultralife for $320 Million in Defense Expansion

EnerSys (ENS) will acquire Ultralife (ULBI) for $320M, paying $16/share, a 166% premium. The deal, expected to close Q1 2027, aims to expand EnerSys' defense battery business, adding manufacturing capacity and technologies. Ultralife generated $191M revenue in 2025. EnerSys expects $15-20M in annual cost savings and EPS growth post-acquisition.

$ULBIHighAI 8/10

Orders waiting to be filled at Ultralife hit $136 million, its highest level ever.

Ultralife Corporation (ULBI) reported Q3 2026 revenue of $48.3M, up from $43.4M in Q3 2025. Gross profit rose to $13.3M (27.5% of revenue) from $9.6M (22.2%). Operating income was $3.2M, reversing a $1.0M loss in the prior year. GAAP EPS was $0.14, compared to ($0.07). Adjusted EBITDA reached $5.6M, up from $2.0M. Backlog hit $136.0M, the highest ever. Ultralife also announced an agreement to be acquired by EnerSys (ENS) in an all-cash transaction.

$ULBIMed

Freedom: Ultralife upside after acquisition announcement is almost exhausted

Ultralife (ULBI) shares rose 145.4% to $15.61 after EnerSys (ENS) agreed to acquire it for $16 per share, a 166% premium. The deal, valued at $320M, is expected to close in Q1 2027. Analyst Vladimir Chernov sees limited upside for ULBI, with shares likely staying in the $15.5–16 range until the deal closes. ENS expects cost savings and EPS growth post-acquisition.